Dora Kholodenko
Impact in
- Physiology top 0.2%
- Alzheimer's disease research and treatments
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Alzheimer's disease research and treatments 9
-
- Prion Diseases and Protein Misfolding 2
- Co-authors
- Lisa McConlogue (2 shared papers)Kang Hu (2 shared papers)Gwen Tatsuno (2 shared papers)Lennart Mucke (2 shared papers)Eliezer Masliah (2 shared papers)Kelly Johnson‐Wood (3 shared papers)Edward Rockenstein (1 shared paper)Gui-Qiu Yu (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Alzheimer s & Dementia (2 papers)Journal of Neuroscience (1 paper)Proceedings of the National Academy of Sciences (1 paper)Neurodegenerative Diseases (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Dora Kholodenko
10 papers receiving 3.8k citations
Dora Kholodenko's Hit Papers
Peers
Comparison fields: 5 of 94
- Physiology 3.1k
- Neurology 682
- Biological Psychiatry 152
- Cellular and Molecular Neuroscience 1.1k
- Pharmacology 752
Countries citing papers authored by Dora Kholodenko
This map shows the geographic impact of Dora Kholodenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Kholodenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Kholodenko more than expected).
Fields of papers citing papers by Dora Kholodenko
This network shows the impact of papers produced by Dora Kholodenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Kholodenko. The network helps show where Dora Kholodenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Kholodenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation Hit paper breakdown → | 2000 | 1549 |
| 2 | Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models Hit paper breakdown → | 1999 | 929 |
| 3 | Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease Hit paper breakdown → | 1995 | 569 |
| 4 | 1998 | 371 | |
| 5 | 1997 | 242 | |
| 6 | 1997 | 156 | |
| 7 | 2008 | 55 | |
| 8 | 2010 | 4 | |
| 9 | 2010 | 3 | |
| 10 | 1996 | 3 |
About Dora Kholodenko
Dora Kholodenko is a scholar working on Physiology, Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience and Neurology, having authored 10 papers that have together received 3.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Prion Diseases and Protein Misfolding (2 papers), Nuclear Receptors and Signaling (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Neuroscience and Neuropharmacology Research (1 paper), Dementia and Cognitive Impairment Research (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Physiology (3.1k citations), Neurology (682 citations), Biological Psychiatry (152 citations), Cellular and Molecular Neuroscience (1.1k citations) and Pharmacology (752 citations). Dora Kholodenko has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Lisa McConlogue, Kang Hu, Gwen Tatsuno, Lennart Mucke, Eliezer Masliah, Kelly Johnson‐Wood, Edward Rockenstein, Gui-Qiu Yu, Margaret Mallory and Peter Seubert. Their work appears in journals such as Journal of Biological Chemistry, Alzheimer s & Dementia, Journal of Neuroscience, Proceedings of the National Academy of Sciences and Neurodegenerative Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.